Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2807/1560-7917.es.2023.28.3.2200195
Publication URI: http://dx.doi.org/10.2807/1560-7917.es.2023.28.3.2200195
Type: Journal Article/Review
Parent Publication: Eurosurveillance
Issue: 3